North Caldwell, NJ, United States of America

James Gordon Christenson


Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 1977-1982

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of James Gordon Christenson

Introduction

James Gordon Christenson is a notable inventor based in North Caldwell, NJ (US). He has made significant contributions to the field of immunology, holding a total of 8 patents. His work primarily focuses on the development of hapten compositions that are crucial for the creation of immunogens.

Latest Patents

Among his latest patents, Christenson has developed novel hapten compositions consisting of 4-[4-[2-(aminopropyl)]phenyl]butanoic acid and its N-methyl derivative. These compositions are instrumental in preparing immunogens that can elicit antibodies selective to amphetamine and methamphetamine. Additionally, he has described a sensitive radioimmunoassay for methaqualone and its major metabolites. This patent includes the preparation of novel methaqualone haptens and the use of antigens to elicit antibodies specific to methaqualone and its metabolites.

Career Highlights

Christenson is currently associated with Hoffmann-La Roche Inc., where he continues to innovate in the field of immunology. His work has had a significant impact on the development of immunoassays, which are essential for detecting specific compounds in various samples.

Collaborations

Throughout his career, Christenson has collaborated with notable colleagues, including Benjamin Pecherer and Richard William Avenia. These collaborations have further enhanced the scope and impact of his research.

Conclusion

James Gordon Christenson's contributions to immunology through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the development of immunoassays and the understanding of drug detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…